Mycetoma: The PLOS NTDs Collection

Another one with Dr. Aksoy:

Mycetoma: The PLOS NTDs Collection

 

Will Zika become the 2016 NTD of the Year?

A PLOS Speaking of Medicine editorial by Dr. Serap Aksoy and me:

Will Zika become the 2016 NTD of the Year?

 

The Onchocerciasis Vaccine for Africa—TOVA—Initiative

Hotez et al.

An onchocerciasis vaccine for Africa would build on past investments in OCP and APOC and support future investments planned under PENDA to help achieve elimination of onchocerciasis. TOVA has begun to explore innovative financing mechanisms from major foundations, governments in North America, Europe, and elsewhere, as well as some of the major development banks committed to poverty reduction in sub-Saharan Africa. We strongly encourage the global public health community to embrace the prospect of an onchocerciasis vaccine and to incorporate plans for a vaccine’s development into future public policy and strategic plan considerations.

Read the rest of the article here

The NTDs and Vaccine Diplomacy in Latin America: Opportunities for United States Foreign Policy

Recently published prevalence estimates of neglected tropical diseases (NTDs) in five Latin American countries—Bolivia, Cuba, Ecuador, Nicaragua, and Venezuela—could suggest a new direction for United States foreign policy in the region.

In their 2008 report entitled “US–Latin America Relations: A New Direction for A New Reality,” the Council on Foreign Relations highlighted dramatic and recent shifts in US foreign policy towards Latin America. Briefly stated, following a period of 150 years of US hegemony in the Latin American and Caribbean (LAC) region under the auspices of the Monroe Doctrine, increasingly, LAC nations are looking to other partners such as China and India, as well as the Middle East. In parallel, favorable attitudes towards the US have dropped to unprecedented lows in many LAC countries.

read the rest of the article here